Study Overview: This study aims to understand how safe and tolerable a medication called cariprazine is for children and teens who have schizophrenia, bipolar I disorder, or autism spectrum disorder (ASD). Cariprazine is a drug that helps manage symptoms of these conditions. The study will observe how well children handle the medication over a long period.

Eligibility: To join, participants must have one of the three conditions confirmed by a special test, the K-SADS-PL. They also need normal health check results unless doctors say otherwise. A caregiver must be available to help with study responsibilities. Children with certain other mental health conditions or severe intellectual disabilities cannot participate.

• This is a long-term study. Ensure your child can commit to regular visits.
• Participants will receive the study medication, cariprazine.
• The study will monitor for any side effects or benefits of the medication.